{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:11:58Z","timestamp":1789776718921,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtos.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:49:21Z","timestamp":1727293761000},"page":"370-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Development of human amniotic epithelial cell-derived extracellular vesicles as cell-free therapy for dry eye disease"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-4830","authenticated-orcid":false,"given":"Soojin","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Gyem","family":"Yae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9283-3506","authenticated-orcid":false,"given":"Hong Kyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2024.09.006_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/OPTH.S228838","article-title":"Managing dry eye disease and facilitating realistic patient expectations: a review and appraisal of current therapies","volume":"14","author":"Shen Lee","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/ijms24010731","article-title":"The potential role of regulated cell death in dry eye diseases and ocular surface dysfunction","volume":"24","author":"Scarpellini","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106206","article-title":"Current trends in pharmaceutical treatment of dry eye disease: a review","volume":"175","author":"Mohamed","year":"2022","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100842","article-title":"Advances in the diagnosis and treatment of dry eye","volume":"78","author":"Kojima","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2024.09.006_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2147\/OPTH.S184412","article-title":"Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease","volume":"13","author":"de Oliveira","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","article-title":"Diagnosing the severity of dry eye: a clear and practical algorithm","volume":"98","author":"Baudouin","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib7","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/jcm8091478","article-title":"Blood-based treatments for severe dry eye disease: the need of a consensus","volume":"8","author":"Bernabei","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtos.2024.09.006_bib8","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3390\/ijms18112264","article-title":"Regenerative therapies in dry eye disease: from growth factors to cell therapy","volume":"18","author":"Villatoro","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4103\/IJO.IJO_2806_22","article-title":"Newer approaches to dry eye therapy: nanotechnology, regenerative medicine, and tissue engineering","volume":"71","author":"Joshi","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111307","article-title":"A synthetic tear protein resolves dry eye through promoting corneal nerve regeneration","volume":"40","author":"Efraim","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib11","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1038\/s41598-022-12879-x","article-title":"Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease","volume":"12","author":"Metheetrairut","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib12","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.2147\/OPTH.S391536","article-title":"Effect of autologous platelet-rich plasma drops in the treatment of ocular surface disease","volume":"16","author":"Nadelmann","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","article-title":"Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study","volume":"6","author":"Alio","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2024.09.006_bib14","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.2147\/OPTH.S322079","article-title":"Corneal epithelial stem cell supernatant in the treatment of severe dry eye disease: a pilot study","volume":"15","author":"Rush","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jtos.2019.01.006","article-title":"The therapeutic application of mesenchymal stem cells at the ocular surface","volume":"17","author":"Sahu","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.09.006_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","article-title":"Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease","volume":"19","author":"M\u00f8ller-Hansen","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.09.006_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13287-020-02129-0","article-title":"Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art","volume":"12","author":"Galindo","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jtos.2024.09.006_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/sctm.20-0118","article-title":"Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders","volume":"10","author":"Beeken","year":"2021","journal-title":"STEM CELLS Translational Medicine"},{"key":"10.1016\/j.jtos.2024.09.006_bib19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3389\/fimmu.2019.01645","article-title":"Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application","volume":"10","author":"Caplan","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2024.09.006_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13287-019-1372-0","article-title":"Recent advances of exosomes in immune-mediated eye diseases","volume":"10","author":"Li","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jtos.2024.09.006_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci"},{"key":"10.1016\/j.jtos.2024.09.006_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtos.2024.09.006_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13287-021-02684-0","article-title":"Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge","volume":"13","author":"Elkhenany","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jtos.2024.09.006_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.9.6.12","article-title":"Development of contact lens-shaped crosslinked amniotic membranes for sutureless fixation in the treatment of ocular surface diseases","volume":"9","author":"Yi","year":"2020","journal-title":"Trans. Vis. Sci. Tech."},{"key":"10.1016\/j.jtos.2024.09.006_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11892-020-01316-w","article-title":"Immunomodulatory properties of amniotic membrane derivatives and their potential in regenerative medicine","volume":"20","author":"Wassmer","year":"2020","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib26","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/ijms22042055","article-title":"Exosomes secreted from amniotic membrane contribute to its anti-fibrotic activity","volume":"22","author":"Mao","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.jtos.2024.09.006_bib27","article-title":"Human amniotic fluid stem cell-derived exosomes as a novel cell-free therapy for cutaneous regeneration","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtos.2024.09.006_bib28","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.2147\/IJN.S277190","article-title":"Roles of exosomes in ocular diseases","volume":"15","author":"Liu","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2024.09.006_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.preteyeres.2017.04.004","article-title":"Roles of exosomes in the normal and diseased eye","volume":"59","author":"Klingeborn","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2024.09.006_bib30","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.18632\/aging.103904","article-title":"Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.jtos.2024.09.006_bib31","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","article-title":"Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing","volume":"59","author":"Samaeekia","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157614","article-title":"Amnion-epithelial-cell-derived exosomes demonstrate physiologic state of cell under oxidative stress","volume":"11","author":"Sheller","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.09.006_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/15384101.2021.2020015","article-title":"A survey and critical evaluation of isolation, culture, and cryopreservation methods of human amniotic epithelial cells","volume":"21","author":"Naeem","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jtos.2024.09.006_bib34","doi-asserted-by":"crossref","first-page":"478.e1","DOI":"10.1016\/j.ajog.2018.08.021","article-title":"Amnion epithelial cell derived exosomes induce inflammatory Changes in uterine cells","volume":"219","author":"Hadley","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtos.2024.09.006_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/srep33935","article-title":"A novel affinity-based method for the isolation of highly purified extracellular vesicles","volume":"6","author":"Nakai","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1555419","article-title":"Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent","volume":"8","author":"Rikkert","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtos.2024.09.006_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70393-4","article-title":"The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers","volume":"10","author":"Risha","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s13287-020-02032-8","article-title":"Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jtos.2024.09.006_bib39","article-title":"Identification and characterization of 293T cell-derived exosomes by profiling the protein, mRNA and MicroRNA components","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.09.006_bib40","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtos.2024.09.006_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110584","article-title":"Insight into the proteomic profiling of exosomes secreted by human OM-MSCs reveals a new potential therapy","volume":"131","author":"Xun","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtos.2024.09.006_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3341\/kjo.2019.0046","article-title":"Effect of diquafosol on hyperosmotic stress-induced tumor necrosis factor-\u03b1 and interleukin-6 expression in human corneal epithelial cells","volume":"34","author":"Kim","year":"2020","journal-title":"Kor J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/a-1111-9414","article-title":"Defining the characteristics of osmotic challenge to the ocular surface","volume":"237","author":"Setten","year":"2020","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jtos.2024.09.006_bib44","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/ijms21114169","article-title":"Comparative analysis of age-related Changes in lacrimal glands and meibomian glands of a C57BL\/6 male mouse model","volume":"21","author":"Yoon","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib45","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1167\/iovs.14-13924","article-title":"Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease","volume":"55","author":"Vijmasi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212102","article-title":"Experimental models, induction protocols, and measured parameters in dry eye disease: focusing on practical implications for experimental research","volume":"22","author":"Rahman","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib47","article-title":"In vivo fluorescence imaging of conjunctival goblet cells","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105722","article-title":"Puerarin alleviates hyperosmotic stress-induced oxidative stress, inflammation, apoptosis and barrier damage of human corneal epithelial cells by targeting SIRT1\/NLRP3 signaling","volume":"94","author":"Dong","year":"2024","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.jtos.2024.09.006_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.615508","article-title":"A review of placenta and umbilical cord-derived stem cells and the immunomodulatory basis of their therapeutic potential in bronchopulmonary dysplasia","volume":"9","author":"Chia","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtos.2024.09.006_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13287-020-01951-w","article-title":"Application of human amniotic epithelial cells in regenerative medicine: a systematic review","volume":"11","author":"Zhang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jtos.2024.09.006_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/20417314221122123","article-title":"Human amniotic epithelial cell-derived extracellular vesicles provide an extracellular matrix-based microenvironment for corneal injury repair","volume":"13","author":"Hu","year":"2022","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.jtos.2024.09.006_bib52","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.3390\/ijms21207730","article-title":"Human amniotic epithelial stem cells: a promising seed cell for clinical applications","volume":"21","author":"Qiu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0963689717742819","article-title":"The immunomodulatory properties of amniotic cells: the two sides of the coin","volume":"27","author":"Magatti","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtos.2024.09.006_bib54","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3390\/cells9092123","article-title":"Human amnion epithelial cells impair T cell proliferation: the role of HLA-G and HLA-E molecules","volume":"9","author":"Morandi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jtos.2024.09.006_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-9-29","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtos.2024.09.006_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.aopr.2024.02.001","article-title":"Regenerative treatment of ophthalmic diseases with stem cells: principles, progress, and challenges","volume":"4","author":"Niu","year":"2024","journal-title":"Adv Ophthalmol Pract Res"},{"key":"10.1016\/j.jtos.2024.09.006_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720964381","article-title":"Isolation and differentiation of amniotic membrane stem cells into keratinocytes","volume":"29","author":"Lan","year":"2020","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtos.2024.09.006_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.04.013","article-title":"Extracellular vesicles for tissue repair and regeneration: evidence, challenges and opportunities","volume":"175","author":"Nagelkerke","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2024.09.006_bib60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11033-024-09628-w","article-title":"The comparative effects of bone marrow mesenchymal stem cells and supernatant transplantation on demyelination and inflammation in cuprizone model","volume":"51","author":"Tahmasebi","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00417-011-1841-3","article-title":"Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect","volume":"250","author":"Agorogiannis","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib62","article-title":"Mesenchymal stem cell-derived extracellular vesicles for corneal wound repair","volume":"2019","author":"Tao","year":"2019","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.jtos.2024.09.006_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav8521","article-title":"Advances in therapeutic applications of extracellular vesicles","volume":"11","author":"Wiklander","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtos.2024.09.006_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fcell.2020.00149","article-title":"Mesenchymal stem cell-derived extracellular vesicles: challenges in clinical applications","volume":"8","author":"Gowen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtos.2024.09.006_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100261","article-title":"Exosome engineering: current progress in cargo loading and targeted delivery","volume":"20","author":"Fu","year":"2020","journal-title":"NanoImpact"},{"key":"10.1016\/j.jtos.2024.09.006_bib66","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jtos.2024.09.006_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71337-8","article-title":"hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye","volume":"10","author":"Yu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/cells12010033","article-title":"Mesenchymal stromal cells-derived extracellular vesicles regulate dendritic cell functions in dry eye disease","volume":"12","author":"Guo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jtos.2024.09.006_bib69","article-title":"Topical cell-free conditioned media harvested from adipose tissue-derived stem cells promote recovery from corneal epithelial defects caused by chemical burns","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.09.006_bib70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/sctm.18-0178","article-title":"Corneal wound healing effects of mesenchymal stem cell secretome delivered within a viscoelastic gel carrier","volume":"8","author":"Fernandes-Cunha","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jtos.2024.09.006_bib71","article-title":"Effect of stem cell-derived extracellular vesicles on damaged human corneal endothelial cells","volume":"2021","author":"Nuzzi","year":"2021","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.jtos.2024.09.006_bib72","first-page":"36","article-title":"Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: roles, opportunities and challenges","volume":"10","author":"Ding","year":"2023","journal-title":"Mil Med Res"},{"key":"10.1016\/j.jtos.2024.09.006_bib73","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/pharmaceutics15051486","article-title":"Wound-healing effects of mesenchymal stromal cell secretome in the cornea and the role of exosomes","volume":"15","author":"An","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2024.09.006_bib74","doi-asserted-by":"crossref","first-page":"102","DOI":"10.20517\/evcna.2022.08","article-title":"Mesenchymal stem cell-derived extracellular vesicles for cell-free therapy of ocular diseases","volume":"3","author":"Liu","year":"2022","journal-title":"Extracellular Vesicles and Circulating Nucleic Acids"},{"key":"10.1016\/j.jtos.2024.09.006_bib75","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3389\/fimmu.2017.01626","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning?","volume":"8","author":"Lohan","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2024.09.006_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5966\/sctm.2014-0110","article-title":"Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies","volume":"4","author":"Heslop","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jtos.2024.09.006_bib77","article-title":"MSCs can be a double-edged sword in tumorigenesis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtos.2024.09.006_bib78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","article-title":"Advances in dry eye disease treatment","volume":"30","author":"O'Neil","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2024.09.006_bib79","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/JEP.S237487","article-title":"Experimental pharmacotherapy for dry eye disease: a review","volume":"13","author":"Baiula","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"10.1016\/j.jtos.2024.09.006_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12305","article-title":"Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases","volume":"12","author":"Li","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtos.2024.09.006_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.816698","article-title":"Biological features of extracellular vesicles and challenges","volume":"10","author":"Zeng","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtos.2024.09.006_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.201700040","article-title":"Extracellular vesicles: isolation methods","volume":"1","author":"Pariset","year":"2017","journal-title":"Adv Biosyst"},{"key":"10.1016\/j.jtos.2024.09.006_bib83","article-title":"Comparison study of small extracellular vesicle isolation methods for profiling protein biomarkers in breast cancer liquid biopsies","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2024.09.006_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2024.100041","article-title":"Extracellular vesicle lyophilization for enhanced distribution to the point of care","volume":"3","author":"Golan","year":"2024","journal-title":"Extracellular Vesicle"},{"key":"10.1016\/j.jtos.2024.09.006_bib85","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejpb.2019.08.009","article-title":"The challenges and possibilities of extracellular vesicles as therapeutic vehicles","volume":"144","author":"Melling","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jtos.2024.09.006_bib86","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.2147\/IJN.S225453","article-title":"Extracellular vesicles as nanomedicine: hopes and hurdles in clinical translation","volume":"14","author":"Burnouf","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2024.09.006_bib87","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jtos.2024.09.006_bib88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12951-023-01921-3","article-title":"Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases","volume":"21","author":"Zhu","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.jtos.2024.09.006_bib89","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/pharmaceutics12111006","article-title":"Recent advances in extracellular vesicles as drug delivery systems and their potential in precision medicine","volume":"12","author":"de Jong","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2024.09.006_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"1","key":"10.1016\/j.jtos.2024.09.006_bib91","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1080\/10717544.2022.2104404","article-title":"Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy","volume":"29","author":"Wu","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2024.09.006_bib92","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/10717544.2021.1951896","article-title":"Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation","volume":"28","author":"Yuan","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2024.09.006_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01199","article-title":"To protect and to preserve: novel preservation strategies for extracellular vesicles","volume":"9","author":"Kusuma","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:04:32Z","timestamp":1733465072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":92,"alternative-id":["S1542012424001022"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.09.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of human amniotic epithelial cell-derived extracellular vesicles as cell-free therapy for dry eye disease","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}